Vibigaba (germinated brown rice) and reduction of body weight in the context of an energy-restricted diet: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No1924/2006

被引:0
|
作者
Turck, Dominique
Bresson, Jean-Louis
Burlingame, Barbara
Dean, Tara
Fairweather-Tait, Susan
Heinonen, Marina
Hirsch-Ernst, Karen Ildico
Mangelsdorf, Inge
McArdle, Harry J.
Naska, Androniki
Neuhauser-Berthold, Monika
Nowicka, Grazyna
Pentieva, Kristina
Sanz, Yolanda
Sjodin, Anders
Stern, Martin
Tome, Daniel
Van Loveren, Henk
Vinceti, Marco
Willatts, Peter
Martin, Ambroise
Strain, John Joseph
Siani, Alfonso
机构
关键词
germinated brown rice; Vibigaba; body weight; health claim;
D O I
10.2903/j.efsa.2017.4915
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following an application from Loc Troi group, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No1924/2006 via the Competent Authority of the Netherlands, the EFSA Panelon Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Vibigaba (germinated brown rice) and reduction of body weight in the context of an energy-restricted diet. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Vibigaba. The Panelconsiders that the germinated brown rice Vibigaba is sufficiently characterised. The claimed effect proposed by the applicant is in the context of an energy-restricted diet contributes to weight loss'. The Panelconsiders that reduction of body weight in the context of an energy-restricted diet is a beneficial physiological effect. The Panelnotes that the applicant did not perform a comprehensive literature search to identify human intervention studies which could be pertinent to the claim. The applicant identified one human intervention study as being pertinent to the claim. The Panelnotes the important methodological limitations of the study (e.g. statistical methods used for data analysis not appropriate for the study design) and that the information provided on the design and conduct of the study is insufficient for a complete scientific evaluation. The Panelconsiders that no conclusions can be drawn from this study for the scientific substantiation of the claim. The Panelconcludes that a cause and effect relationship has not been established between the consumption of Vibigaba (germinated brown rice) and reduction of body weight in the context of an energy-restricted diet.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Scientific Opinion on the substantiation of a health claim related to hydroxyanthracene derivatives and improvement of bowel function pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2013, 11 (10):
  • [42] Scientific Opinion on the substantiation of a health claim related to Rosbacher drive (R) and increased attention pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (02)
  • [44] Scientific Opinion on the substantiation of a health claim related to AlphaGOS (R) and a reduction of post-prandial glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjodin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (10)
  • [45] Scientific Opinion on the substantiation of a health claim related to Slendesta (R) Potato Extract and reduction of body weight pursuant to Article 13(5) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhauser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjodin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2013, 11 (02)
  • [46] Scientific Opinion on the substantiation of a health claim related to a standardised aqueous extract from white kidney bean (Phaseolus vulgaris L.) and reduction of body weight pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhauser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjodin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (07)
  • [47] Frutalose®, a mixture of fructans obtained from enzymatic hydrolysis of chicory inulin, and normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Turck, Dominique
    Bohn, Torsten
    Castenmiller, Jacqueline
    De Henauw, Stefaan
    Hirsch-Ernst, Karen Ildico
    Knutsen, Helle Katrine
    Maciuk, Alexandre
    Mangelsdorf, Inge
    McArdle, Harry J.
    Naska, Androniki
    Pelaez, Carmen
    Pentieva, Kristina
    Siani, Alfonso
    Thies, Frank
    Tsabouri, Sophia
    Vinceti, Marco
    EFSA JOURNAL, 2021, 19 (08)
  • [48] Lactobacillus plantarum 299v and an increase of non-haem iron absorption: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Bresson, Jean-Louis
    Burlingame, Barbara
    Dean, Tara
    Fairweather-Tait, Susan
    Heinonen, Marina
    Hirsch-Ernst, Karen Ildico
    Mangelsdorf, Inge
    McArdle, Harry
    Naska, Androniki
    Neuhauser-Berthold, Monika
    Nowicka, Grazyna
    Pentieva, Kristina
    Sanz, Yolanda
    Siani, Alfonso
    Sjodin, Anders
    Stern, Martin
    Tome, Daniel
    Turck, Dominique
    Van Loveren, Hendrik
    Vinceti, Marco
    Willatts, Peter
    EFSA JOURNAL, 2016, 14 (07)
  • [49] Symbiosal® and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
    Turck, Dominique
    Bresson, Jean-Louis
    Burlingame, Barbara
    Dean, Tara
    Fairweather-Tait, Susan
    Heinonen, Marina
    Hirsch-Ernst, Karen Ildico
    Mangelsdorf, Inge
    McArdle, Harry J.
    Naska, Androniki
    Neuhauser-Berthold, Monika
    Nowicka, Grazyna
    Pentieva, Kristina
    Sanz, Yolanda
    Sjodin, Anders
    Stern, Martin
    Tome, Daniel
    Van Loveren, Henk
    Vinceti, Marco
    Willatts, Peter
    Martin, Ambroise
    EFSA JOURNAL, 2018, 16 (07)